FORMULATION, OPTIMIZATION AND IN VITRO EVALUATION OF RIFAMPICIN NANOEMULSIONS
Abstract
The aim of the present investigation was to develop, optimize and evaluate nanoemulsion of rifampicin to improve the solubility, stability and oral bioavailability. Rifampicin nanoemulsions were prepared by o/w nanoemulsion region of the phase diagrams, which were subjected to physical stability and phase separation tests. Prepared rifampicin nanoemulsions were evaluated for particle size, zeta potential, PDI and drug content. In vitro dissolution was performed by using dialysis bag method and morphology by transmission electron microscopy (TEM). Best results were obtained with the formulation which consisted of 10 mg of rifampicin, 15% w/w of sefsol 218, 25% w/w of tween 80, 15% w/w of tween 20 and 45% w/w of water. In vitro release studies revealed that 99.85 ± 1.85% was observed in 12h. TEM studies shows the globules are in spherical shape with dark surroundings. DSC studies revealed that no interaction between the drug and excipients. The optimized formulation was also subjected to stability studies according and was found to be stable for one month with no phase separation. These results indicated the potential of nanoemulsions of rifampicin could be promising to improve solubility, stability and oral bioavailability.
Keywords:
Rifampicin, nanoemulsions, phase diagram, size, TEM, stabilityReferences
2. Uson N, Garcia MJ, Solans C. Formation of water in oil (w/o) nano-emulsions in water /mixed non-ionic surfactant/oil systems prepared by a low energy emulsification method Colloids and surfaces A. Physicochem. Eng. Aspects 2004; 250: 415-21.
3. Shah P, Bhalodia D, Shelat P. Nanoemulsion: A Pharmaceutical Review. Systematic Reviews in Pharmacy 2010; 1(1):24-32.
4. Lovelyn C, Attama AA. Current State of Nanoemulsions in Drug Delivery. Journal of Biomaterials and Nanobiotechnology 2011; 2:626-639.
5. Piddock LJV, Williams KJ, Ricci V. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis. J Anti microbial chemotherapy 2000; 45(2):159-165.
6. Barrow EW, Winchester GA, Staas JK, Quenelle DC, Barrow WW. Use of microsphere technology for targeted delivery of rifampicin to Mycobacterium tuberculosis-infected macrophages. Anti microbial agents chemotherapy 1998; 42:2682-2689.
7. Suvarna G, Dudhipala N, Veerabrahma K. Preparation, Characterization and In vivo Evaluation of Rosuvastatin Calcium Loaded Solid Lipid Nanoparticles. International Journal of Pharmaceutical Sciences and Nanotechnology 2015; 8(1):2779-2785.
8. Dudhipala N, Veerabrahma K. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv, Early Online 2014; 1–10! DOI: 10.3109/10717544.2014.914986.
9. Shafiq S, Faiyaz S, Sushma T, Farhan JA, Khar RK, Ali M. Design and development of ramipril nanoemulsion formulation: In vitro and in vivo assessment. J. Biomed. Nanotechnol. 2007; 3:28–44.
10. Shafiq S, Faiyaz S, Sushma T, Farhan JA, Khar RK, Ali M S. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 2007; 66:227-243.
11. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 2000; 45:89-121.
12. Shinoda K, Kunieda H. Phase Properties of Emulsions: PIT and HLB, in Encyclopedia of Emulsion Technolog (Eds. K. Shinoda and H. H. Kunieda), Marcel Dekker, New York 1983, pp. 337–367.
Published

